1 Min Read
Jan 9 (Reuters) -
* Growth Equity Opportunities Fund reports 11.4 pct stake in Aurinia Pharmaceuticals Inc as of Dec 28, 2016 - SEC filing Source text: bit.ly/2j0citQ Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.